Upregulating TERT gene expression reverses multiple hallmarks of aging

MD Anderson, Rice form Cancer Bioengineering Collaborative

The University of Texas MD Anderson Cancer Center and Rice University formed the Cancer Bioengineering Collaborative to develop innovative technologies and bioengineering approaches to improve cancer research, diagnosis, and treatment.

June 28, 2024

Vol.50 No.26

In Brief

MD Anderson’s Institute for Data Science in Oncology establishes internal advisory council

The Institute for Data Science in Oncology at MD Anderson Cancer Center has established an internal advisory council to identify needs and opportunities for data science development and integration across MD Anderson, advancing work that will yield significant benefits for patients and families.

June 21, 2024

Vol.50 No.25

Clinical Roundup

CAR NK cells with CD28 costimulation improved cell persistence, antitumor activity

Adding CD28 costimulation to cord blood-derived chimeric antigen receptor natural killer cells targeting CD70+ cancers significantly enhanced antitumor efficacy and long-term cytotoxicity of the CAR NK cells, according to researchers from MD Anderson Cancer Center.

June 21, 2024

Vol.50 No.25

Clinical Roundup

T-cell aging not limited by organismal age, allowing healthy cells to proliferate in perpetuity

While most cell types experience a functional decline after years of proliferation and replication, T cells can proliferate seemingly indefinitely and without detriment.

June 14, 2024

Vol.50 No.24

Clinical Roundup

MD Anderson, Sibylla Biotech collaborate to develop small-molecule protein degraders

The University of Texas MD Anderson Cancer Center and Sibylla Biotech announced a strategic collaboration agreement to discover and develop novel small-molecule cancer therapies known as folding interfering degraders, which disrupt the proper folding of target proteins and lead to their degradation.

June 14, 2024

Vol.50 No.24

Clinical Trials & Tribulations

Paired tumor-germline testing can enhance patient care—with guidance from genetics specialists

In May, the American Society of Clinical Oncology released guidelines on the use of germline genetic testing panels in concert with tumor testing for cancer patients. xxx:more

June 07, 2024

Vol.50 No.23

By Rebecca Sutphen

Upregulating TERT gene expression reverses multiple hallmarks of aging

YOU MAY BE INTERESTED IN

MD Anderson, Rice form Cancer Bioengineering Collaborative

MD Anderson’s Institute for Data Science in Oncology establishes internal advisory council

CAR NK cells with CD28 costimulation improved cell persistence, antitumor activity

T-cell aging not limited by organismal age, allowing healthy cells to proliferate in perpetuity

MD Anderson, Sibylla Biotech collaborate to develop small-molecule protein degraders

Paired tumor-germline testing can enhance patient care—with guidance from genetics specialists

Renew today!

Subscriber content

Login